CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shenzhen Neptunus Interlong Bio-technique Co Ltd Company Snapshot
Shenzhen Neptunus Interlong Bio-technique Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Neptunus Interlong Bio-technique Co Ltd with three other companies in this sector in China: Shanxi C&Y Pharmaceutical Group Co Ltd (2016 sales of 745.95 million Chinese Renmimbi [US$113.17 million] of which 74% was Pharmaceutical Manufacturing), Jiangxi Fuxiang Pharmaceutical Co Ltd (763.68 million Chinese Renmimbi [US$115.87 million] of which 100% was Pharmaceutical manufacturing industry), and Wuhan Hiteck Biological Pharma Co Ltd (770.94 million Chinese Renmimbi [US$116.97 million] ).

Sales Analysis. During the year ended December of 2016, sales at Shenzhen Neptunus Interlong Bio-technique Co Ltd were 759.11 million Chinese Renmimbi (US$115.17 million). This is an increase of 5.2% versus 2015, when the company's sales were 721.35 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shenzhen Neptunus Interlong Bio-technique Co Ltd (and since 2011, sales have increased a total of 60%). Sales of Research and Development Services saw an increase that was more than double the company's growth rate: sales were up 200.0% in 2016, from 63,000.00 Chinese Renmimbi to 189,000.00 Chinese Renmimbi. Shenzhen Neptunus Interlong Bio-technique Co Ltd also saw significant increases in sales in Purchase and Sales of Medicines and Health (up 23.9% to 328.07 million Chinese Renmimbi) . Not all segments of Shenzhen Neptunus Interlong Bio-technique Co Ltd experienced an increase in sales in 2016: sales of Manufacturing and Selling Medicine Products fell 5.6% to 430.86 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shenzhen Neptunus Interlong Bio-technique Co Ltd
  Stock Performance Chart for Shenzhen Neptunus Interlong Bio-technique Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/22/2017): .30
(Figures in Chinese Renmimbi)
1 Week 3.7%   13 Weeks -6.1%  
4 Weeks -31.9%   52 Weeks -40.8%  
 
Shenzhen Neptunus Interlong Bio-technique Co Ltd Key Data:
  Ticker: 8329 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 759,111,000
(Year Ending Jan 2017).
Employees: 1,251
  Currency: Chinese Renmimbi Market Cap: 495,765,100
  Fiscal Yr Ends: December Shares Outstanding: 1,678,000,000
  Share Type: H Gu Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.